Effect of adlay seed extract on inflammation and fibrogenesis in human corneal activated keratocytes at transcriptional level
Experimental Eye Research · 2023
DOI: 10.1016/j.exer.2023.109641 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Eye Research, 2023. Verfasst von Fatemeh Sanie-Jahromi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Poostchi Ophthalmology Research Center, Department of Ophthalmology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. Electro…. Hauptthemen laut MEDLINE: Interleukin-6, Corneal Diseases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Shiraz University of Medical Sciences.
Abstract (Originalsprache)
Corneal activated keratocytes (CAKs) -representing the injured phenotype of corneal stromal cells- are associated with several corneal diseases. Inflammatory cytokines are the key drivers of CAK formation subsequently leading to fibrogenesis. This study aimed to investigate the effect of adlay seed extract on the expression of genes involved in inflammation (IL-6, IL-1b, LIF) and fibrogenesis (TGF-β) in CAK cells. CAKs (106 cells/10 cm2) were exposed to methanolic (MeOH) and residual (Res) extract of adlay seed (1 mg/ml, 24 h). The control group received the vehicle solution without extract at the same time and condition. Then, RNA extraction, cDNA synthesis, and real-time PCR were performed to quantify the relative expression of IL-6, IL-1b, LIF, and TGF-β in the treated vs. control cells. This study showed that the MeOH extract of adlay seed could significantly downregulate the expression of IL-6 and IL-1b in the CAKs, while the Res extract led to a significant decrease in TGF-β gene expression. We showed that CAK treatment with adlay seed extract could decrease the expression of genes related to inflammation and fibrogenesis. However, the genes to be targeted depended on the method of extraction. This proof-of-concept study could provide groundwork for the treatment of corneal stromal diseases and ocular regenerative medicine in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Poostchi Ophthalmology Research Center, Department of Ophthalmology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. Electronic address: fsanie@sums.ac.ir.
- Department of Ophthalmology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. Electronic address: mohsenzadeh@sums.ac.ir.
- Pharmacognosy Department, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran. Electronic address: Namjoyan@yahoo.com.
- Poostchi Ophthalmology Research Center, Department of Ophthalmology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran; Department of Cell and Molecular Biology, Faculty of Chemistry, University of…
- Poostchi Ophthalmology Research Center, Department of Ophthalmology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. Electronic address: nejabatm@sums.ac.ir.
Förderung
- Shiraz University of Medical Sciences
Zitieren
APA
Sanie-Jahromi, F., Mohsenzadeh, A. H., Namjoyan, F., Gharegezloo, Z., & Nejabat, M. (2023). Effect of adlay seed extract on inflammation and fibrogenesis in human corneal activated keratocytes at transcriptional level. Experimental Eye Research. https://doi.org/10.1016/j.exer.2023.109641
Vancouver
Sanie-Jahromi F, Mohsenzadeh AH, Namjoyan F, Gharegezloo Z, Nejabat M. Effect of adlay seed extract on inflammation and fibrogenesis in human corneal activated keratocytes at transcriptional level. Experimental Eye Research. 2023. doi:10.1016/j.exer.2023.109641
BibTeX
@article{SanieJahromi2023,
author = {Sanie-Jahromi, Fatemeh and Mohsenzadeh, Amir Hossein and Namjoyan, Foroogh and Gharegezloo, Zahra and Nejabat, Mahmood},
title = {Effect of adlay seed extract on inflammation and fibrogenesis in human corneal activated keratocytes at transcriptional level},
journal = {Experimental Eye Research},
year = {2023},
doi = {10.1016/j.exer.2023.109641}
}
EUVIMED